Alterations in serum sialyltransferase activities in patients with brain tumors.
The activities of serum sialyltransferase were determined in patients with brain tumors. Blood samples from normal volunteers were used as controls. Serum specimens were obtained from patients with brain tumors both before and after operations. The preoperative serum sialyltransferase activities of the brain metastasis group showed significant increase, but the enzyme levels decreased after removal of the tumor. The serum sialyltransferase activities in the glioma group and the neurilemoma group increased significantly after operation, but no significant difference was found between the preoperative means of these two groups and that of the control. Surgical treatment produced significant differences between the preoperative and the postoperative serum sialyltransferase activities in the brain metastasis and the glioma and neurilemoma groups. Alterations of this enzyme in the blood of patients with brain tumors and its possible clinical applications are discussed.
D000236:Adenoma / Q000201:enzymology; D001932:Brain Neoplasms / Q000201:enzymology*; D005910:Glioma / Q000201:enzymology; D006801:Humans; D008579:Meningioma / Q000201:enzymology; D009442:Neurilemmoma / Q000201:enzymology; D010911:Pituitary Neoplasms / Q000201:enzymology; D012799:Sialyltransferases / Q000097:blood*; D014166:Transferases / Q000097:blood*; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase
D014166:Transferases; D012799:Sialyltransferases; D000094802:beta-D-Galactoside alpha 2-6-Sialyltransferase